- Home
- NDRA vs SNOA Comparison
NDRA vs SNOA Comparison
Compare NDRA & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- SNOA
- Stock Information
- Founded
- NDRA 2007
- SNOA 1999
- Country
- NDRA United States
- SNOA United States
- Employees
- NDRA N/A
- SNOA N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- NDRA Health Care
- SNOA Health Care
- Exchange
- NDRA Nasdaq
- SNOA Nasdaq
- Market Cap
- NDRA 7.3M
- SNOA 6.5M
- IPO Year
- NDRA 2017
- SNOA 2007
- Fundamental
- Price
- NDRA $4.53
- SNOA $3.16
- Analyst Decision
- NDRA Strong Buy
- SNOA
- Analyst Count
- NDRA 1
- SNOA 0
- Target Price
- NDRA $38.00
- SNOA N/A
- AVG Volume (30 Days)
- NDRA 45.9K
- SNOA 30.5K
- Earning Date
- NDRA 11-17-2025
- SNOA 11-04-2025
- Dividend Yield
- NDRA N/A
- SNOA N/A
- EPS Growth
- NDRA N/A
- SNOA N/A
- EPS
- NDRA N/A
- SNOA N/A
- Revenue
- NDRA N/A
- SNOA $16,937,000.00
- Revenue This Year
- NDRA N/A
- SNOA $23.00
- Revenue Next Year
- NDRA N/A
- SNOA $24.59
- P/E Ratio
- NDRA N/A
- SNOA N/A
- Revenue Growth
- NDRA N/A
- SNOA 25.02
- 52 Week Low
- NDRA $2.90
- SNOA $1.75
- 52 Week High
- NDRA $11.96
- SNOA $6.92
- Technical
- Relative Strength Index (RSI)
- NDRA 42.26
- SNOA 39.10
- Support Level
- NDRA $6.06
- SNOA $3.25
- Resistance Level
- NDRA $6.80
- SNOA $3.57
- Average True Range (ATR)
- NDRA 0.84
- SNOA 0.22
- MACD
- NDRA -0.12
- SNOA -0.03
- Stochastic Oscillator
- NDRA 23.44
- SNOA 29.37
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.